Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer

Oncogene(2024)10.1038/s41388-024-03252-5Source: DataRank Database

A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer is a research paper published in Oncogene (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

geo dbgap doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.38)OA: hybridTopics (67)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Hamed Khedmatgozar,Girijesh Kumar Patel ORCID,Daniel Latour,Jonathan Welsh,Mainak Mustafi ORCID

Live enrichment

PubMed:39702503 PMC:PMC11932930 OpenAlex:https://openalex.org/W4405584309

NLM NIH HHS

Grant: R01 LM013236

U.S. Department of Defense (United States Department of Defense)

Grant: W81XWH-16-1-0174

U.S. Department of Defense (United States Department of Defense)

Grant: W81XWH-17-1-0353

Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)

Grant: RP210154

National Institutes of Health

Grant: 1R01LM013236-01A1

Generalizable biomedical informatics strategies for predictive modeling of treatment response

FWCI

1.38

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.nature.com/articles/s41388-024-03252-5.pdf

publisherhttps://www.nature.com/articles/s41388-024-03252-5.pdf

publisherhttps://www.nature.com/articles/s41388-024-03252-5

journalhttps://doi.org/10.1038/s41388-024-03252-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39702503

Fields of Study

Prostate Cancer Treatment and ResearchHormonal and reproductive studiesSexual Differentiation and Disorders03 medical and health sciences0302 clinical medicineHumansMaleReceptors, AndrogenReceptors, GlucocorticoidDrug Resistance, NeoplasmT-Box Domain ProteinsSignal TransductionPhenylthiohydantoinCell Line, TumorBenzamidesNitrilesProstatic NeoplasmsGene Expression Regulation, NeoplasticProstatic Neoplasms, Castration-Resistant

MeSH Terms

BenzamidesHumansMaleNitrilesPhenylthiohydantoinProstatic NeoplasmsReceptors, AndrogenReceptors, GlucocorticoidSignal TransductionGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmT-Box Domain ProteinsCell Line, TumorProstatic Neoplasms, Castration-Resistant

Keywords

Androgen receptorEnzalutamideProstate cancerBiologyGlucocorticoid receptorCancer researchTranscription factorSignal transductionPsychological repressionDemethylaseReceptorBioinformaticsGlucocorticoidCell biologyCancerEndocrinologyHistoneGeneticsGene expressionGeneMaleProstatic NeoplasmsArticleGene Expression Regulation, NeoplasticProstatic Neoplasms, Castration-ResistantReceptors, GlucocorticoidReceptors, AndrogenDrug Resistance, NeoplasmCell Line, TumorPhenylthiohydantoinBenzamidesNitrilesHumansT-Box Domain Proteins

Sustainable Development Goals

SDG 0: Good health and well-being